Edition:
India

Haemonetics Corp (HAE.N)

HAE.N on New York Stock Exchange

36.21USD
30 Sep 2016
Change (% chg)

$0.50 (+1.40%)
Prev Close
$35.71
Open
$36.06
Day's High
$36.45
Day's Low
$35.60
Volume
116,544
Avg. Vol
103,351
52-wk High
$38.05
52-wk Low
$25.98

HAE.N

Chart for HAE.N

About

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $1,857.48
Shares Outstanding(Mil.): 51.30
Dividend: --
Yield (%): --

Financials

BRIEF-Haemonetics Corp Q1 adjusted earnings per share $0.25

* Q1 fiscal 2017 revenue of $210.0 million; Q1 earnings per share $0.20; Q1 adjusted earnings per share $0.25

01 Aug 2016

BRIEF-Haemonetics appoints Bill Burke CFO

* Burke will join company from Medtronic Inc Source text for Eikon: Further company coverage:

01 Aug 2016

BRIEF-Haemonetics plans repositioning organization, reduce number of employees

* On may 6, 2016, co committed to a plan for repositioning organization and cost structure; this involves reduction in number of employees

10 May 2016

BRIEF-Haemonetics Corp announces Christopher Simon as CEO

* Haemonetics corporation announces Christopher Simon as president and chief executive officer

10 May 2016

BRIEF-Haemonetics Corp sees FY 2017 adjusted earnings per share $1.40-$1.50

* FY2017 earnings per share view $1.55, revenue view $911.3 million -- Thomson Reuters I/B/E/S

10 May 2016

BRIEF-Haemonetics Q4 GAAP loss per share $0.17

* Haemonetics reports 4th quarter fiscal 2016 revenue of $243 million, constant currency revenue growth of 10% and 7% as reported; fiscal 2016 revenue of $910 million, constant currency revenue growth of 3% and flat as reported

02 May 2016

Competitors

Earnings vs. Estimates